Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ZVRACompany Name
ZEVRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQZEVRA THERAPEUTICS INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ZVRA - EV/FCF Historical data
| Date | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 674.71M | 0 | $ -46.53M |
| 3/31/2025 | $ 454.83M | 0 | $ -61.82M |
| 12/31/2024 | $ 455.11M | 0 | $ -69.67M |
| 9/30/2024 | $ 468.12M | 0 | $ -69.64M |
| 6/30/2024 | $ 388.01M | 0 | $ -56.3M |
| 3/31/2024 | $ 211.96M | 0 | $ -45.92M |
| 12/31/2023 | $ 224.8M | 0 | $ -33.83M |
| 9/30/2023 | $ 160.91M | 0 | $ -22.1M |
| 6/30/2023 | $ 130.83M | 0 | $ -23.92M |
| 3/31/2023 | $ 121.66M | 0 | $ -19.38M |
Key Performance Insights, Last 5 Years
- ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) EV/FCF stands at 0.
- Over the past 5 years, ZEVRA THERAPEUTICS INC's average EV/FCF has been 11.51.
- The median EV/FCF for ZEVRA THERAPEUTICS INC during this period was 11.04
- ZEVRA THERAPEUTICS INC reached its highest EV/FCF over the past 5 years at 18.94.
- The lowest EV/FCF recorded by ZEVRA THERAPEUTICS INC in the same timeframe 5.01
ZEVRA THERAPEUTICS INC's EV/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/FCF Benchmarks
Similar metrics to FCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Definition of Enterprise Value over Free Cash Flow
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].EV / FCF
(=) EV/FCF EV/FCF for ZEVRA THERAPEUTICS INC is calculated as follows: EV [ $ 104.59M ] / FCF [ $ -3.99M ]
(=) EV/FCF [ 0 ] ZVRA - Enterprise Value over Free Cash Flow, Last 5 years
5.01
Minimum
Mar 31, 2022
18.94
Maximum
Sep 30, 2021
11.51
Average
11.04
Median
EV/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.44 with a standard deviation of 16.12.
The following table provides additional summary stats:
EV/FCF in the Market:
| filtered constituents | 2.2K |
|---|---|
| min | 0.05 |
| max | 77.98 |
| average | 23.44 |
| median | 19.08 |
| std | 16.12 |